Daniel Moorhead - Zynex Chief Officer
| ZYXI Stock | USD 8.34 0.08 0.97% |
Executive
Mr. Daniel J. Moorhead is Chief Financial Officer of the company. He served as Chief Financial Officer of Evolving Systems, Inc. from January 1, 2016 until June 2, 2017, after having served as Vice President of Finance Administration from December 2011 through December 2015. He served as Corporationrationrate Controller for Evolving Systems from 2002 to 2005 and rejoined the company in December 2008 in this same role. From August 2005 to November 2008, he was Chief Financial Officer for High Country Club, a destination club. Prior to 2002, he was the Assistant Controller at Convergent Communications and Auditor at Malouff and Co., P.C since 2017.
| Age | 52 |
| Tenure | 7 years |
| Professional Marks | CPA |
| Address | 9655 Maroon Circle, Englewood, CO, United States, 80112 |
| Phone | 303 703 4906 |
| Web | https://www.zynex.com |
Daniel Moorhead Latest Insider Activity
Tracking and analyzing the buying and selling activities of Daniel Moorhead against Zynex stock is an integral part of due diligence when investing in Zynex. Daniel Moorhead insider activity provides valuable insight into whether Zynex is net buyers or sellers over its current business cycle. Note, Zynex insiders must abide by specific rules, including filing SEC forms every time they buy or sell Zynex'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Daniel Moorhead over two months ago Disposition of 15000 shares by Daniel Moorhead of Zynex at 8.24 subject to Rule 16b-3 | ||
Daniel Moorhead over two months ago Acquisition by Daniel Moorhead of 5000 shares of Zynex subject to Rule 16b-3 | ||
Daniel Moorhead over two months ago Disposition of 5250 shares by Daniel Moorhead of Zynex at 7.89 subject to Rule 16b-3 | ||
Daniel Moorhead over three months ago Disposition of 15000 shares by Daniel Moorhead of Zynex at 8.24 subject to Rule 16b-3 |
Zynex Management Efficiency
The company has return on total asset (ROA) of 0.0399 % which means that it generated a profit of $0.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1023 %, meaning that it created $0.1023 on every $100 dollars invested by stockholders. Zynex's management efficiency ratios could be used to measure how well Zynex manages its routine affairs as well as how well it operates its assets and liabilities. The Zynex's current Return On Tangible Assets is estimated to increase to 0.09. The Zynex's current Return On Capital Employed is estimated to increase to 0.1. As of now, Zynex's Non Current Assets Total are increasing as compared to previous years. The Zynex's current Non Currrent Assets Other is estimated to increase to about 429.4 K, while Other Assets are projected to decrease to 0.95.Similar Executives
| Found 13 records | EXECUTIVE Age | ||
| Michael Campana | Healthcare Triangle | N/A | |
| Eugene Johnston | Mangoceuticals, Common Stock | 60 | |
| Amanda Hammer | Mangoceuticals, Common Stock | 38 | |
| Esq JD | Nutex Health | 60 | |
| Damian David | Healthcare Triangle | N/A | |
| Abhay Borwankar | Healthcare Triangle | N/A | |
| Richa Gujarati | Heartbeam | N/A | |
| Timothy Cruickshank | Heartbeam | 43 | |
| Kenneth Persen | Heartbeam | N/A | |
| Anand Kumar | Healthcare Triangle | 50 | |
| Michael MD | Nutex Health | 53 | |
| Yew CPA | EUDA Health Holdings | 56 | |
| MBA FACHE | Nutex Health | N/A | |
Management Performance
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0399 |
Zynex Inc Leadership Team
Elected by the shareholders, the Zynex's board of directors comprises two types of representatives: Zynex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zynex. The board's role is to monitor Zynex's management team and ensure that shareholders' interests are well served. Zynex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zynex's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Sandgaard, Chairman, CEO and President Principal Financial Officer and Principal Accounting Officer | ||
| Anna Lucsok, Chief Officer | ||
| Dave Anttila, Director HR | ||
| Daniel Moorhead, Chief Officer | ||
| Daniel CPA, Chief Officer | ||
| Steve Fox, Executive Sales | ||
| Chelle Burkleo, VP Sales | ||
| Donald Gregg, President Solutions | ||
| Joachim Sandgaard, Information Mang | ||
| Neil Friery, I Solutions |
Zynex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zynex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0399 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 300.1 M | ||||
| Shares Outstanding | 31.85 M | ||||
| Shares Owned By Insiders | 51.27 % | ||||
| Shares Owned By Institutions | 28.00 % | ||||
| Number Of Shares Shorted | 4.83 M | ||||
| Price To Earning | 28.60 X |
Currently Active Assets on Macroaxis
When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 0.14 | Revenue Per Share 5.984 | Quarterly Revenue Growth 0.001 | Return On Assets 0.0399 |
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.